Phase 3 NT-501 Trial
August 27, 2018 11:03 amCNTF-Secreting Cells for Treatment of MacTel Neurotech Pharmaceuticals, with support from the Lowy Medical Research Institute, is testing the safety... View Article
CNTF-Secreting Cells for Treatment of MacTel Neurotech Pharmaceuticals, with support from the Lowy Medical Research Institute, is testing the safety... View Article
Cecinio C. Ronquillo, Kimberley Wegner, Charles M. Calvo, Paul S. Bernstein. JAMA Ophthalmology, 09 August 2018. doi:10.1001/jamaophthalmol.2018.3283
Spaide, Richard F., Yannuzzi, Lawrence A., Maloca, Peter M. Retina, 08 August 2018. doi: 10.1097/IAE.0000000000002289
Dr. Metallo is exploring the role of metabolic dysregulation in MacTel. Genetics and metabolomics studies have indicated that some MacTel... View Article
The Lee Lab at the University of Washington specializes in next-generation computer techniques in the fields of Big Data, Machine... View Article
Genome-wide association studies of macular telangiectasia type 2 (MacTel) show the strongest genetic linkage to a critical non-coding region within... View Article
Lois E. H. Smith M.D., Ph.D. is an ophthalmologist and clinician/scientist at Boston Children’s Hospital and Professor of Ophthalmology at... View Article
Simone Müller, Tjebo F C Heeren, Roberto Bonelli, Marcus Fruttiger, Peter Charbel Issa, Catherine A Egan, Frank G Holz. British Journal of Ophthalmology. 01 June 2018. doi: 10.1136/bjophthalmol-2017-311785
The Lowy Medical Research Institute held its 2018 Annual Meeting in New York, NY on May 10-13 at the University Club of New York. A summary of meeting highlights can be found in the MacTel Project newsletter.
February 9-11, 2018, Rancho Santa Fe, San Diego. Members of the Board of Scientific Governors, scientific collaborators, and Lowy Medical... View Article